Compounds > isosorbide dinitrate
Page last updated: 2024-08-17

isosorbide dinitrate and ivabradine

isosorbide dinitrate has been researched along with ivabradine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lim, WY; Woldman, S1
Dixit, D; Kimborowicz, K1
Enseleit, F; Flammer, AJ; Naegele, M; Ruschitzka, F1
Adhyaru, B; Raj, L1
Wu, A1

Reviews

5 review(s) available for isosorbide dinitrate and ivabradine

ArticleYear
Pharmacological management of chronic heart failure: old drugs, new drugs and new indications.
    British journal of hospital medicine (London, England : 2005), 2013, Volume: 74, Issue:2

    Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiovascular Agents; Chronic Disease; Digoxin; Drug Combinations; Heart Failure; Heart Failure, Systolic; Humans; Hydralazine; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists

2013
Pharmacologic management of chronic stable angina.
    JAAPA : official journal of the American Academy of Physician Assistants, 2015, Volume: 28, Issue:6

    Topics: Adrenergic beta-Antagonists; Angina, Stable; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Humans; Isosorbide Dinitrate; Ivabradine; Nicorandil; Nitroglycerin; Ranolazine; Sodium Channel Blockers; Vasodilator Agents

2015
Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments.
    Swiss medical weekly, 2016, Volume: 146

    Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Neprilysin; Stroke Volume; Vasodilator Agents

2016
An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).
    Postgraduate medical journal, 2016, Volume: 92, Issue:1094

    Topics: Adrenergic beta-Antagonists; American Heart Association; Amides; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Atrial Natriuretic Factor; Benzazepines; Biphenyl Compounds; Calcium Channel Blockers; Cardiology; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Drug Combinations; Erythropoietin; Evidence-Based Medicine; Fumarates; Heart Failure; Hematinics; Humans; Hydralazine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Societies, Medical; Stroke Volume; Tetrazoles; United States; Valsartan; Vasodilator Agents

2016
Heart Failure.
    Annals of internal medicine, 2018, 06-05, Volume: 168, Issue:11

    Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Cardiac Rehabilitation; Cardiovascular Agents; Coronary Artery Disease; Defibrillators, Implantable; Diabetes Complications; Diagnostic Techniques, Cardiovascular; Digoxin; Diuretics; Heart Failure; Hospitalization; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Ivabradine; Life Style; Mineralocorticoid Receptor Antagonists; Palliative Care; Primary Prevention; Referral and Consultation; Risk Factors

2018